Litigation that could cost the company billions has it on the offensive — and asking for the government to intervene.

On Friday, the three-judge appellate panel said only six Illinois families will continue with their infant-formula injury ...

The Food and Drug Administration failed to heed warning signs that there were mounting concerns with one of the nation's largest infant formula makers, as a series of babies' severe illnesses and ...

A jury today found that Abbott Laboratories’ specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay $495 million ...

(NEW YORK) — Abbott is being investigated by the Securities and Exchange Commission, as well as the Federal Trade Commission, in relation to their infant formula business, the company disclosed in a ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The U.S. Food and Drug Administration took ...

Similac baby formula maker Abbott is expected to face a trial on Monday over claims that its formula for preterm infants used in neonatal intensive care units causes a potentially deadly bowel disease ...

(Reuters) -A jury on Friday found that Abbott Laboratories' specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to ...

ABBOTT PARK, Ill., Aug. 27, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the expansion of its Pure Bliss ™ by Similac ® line of organic, and European-made infant formulas that give parents ...

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The U.S. Food and Drug Administration took more than 15 months to act on a whistleblower complaint it received about conditions at an Abbott Nutrition factory that was at the center of a nationwide ...